Landos Biopharma (LABP) Competitor Comparison
We are evaluating the key criteria listed to compare Landos Biopharma (LABP) against its competitors in the Biotechnology industry.
Market Capitalization
327 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
96 / 337Free Cashflow
110 / 352Quick Ratio
120 / 357Earnings per Share
282 / 359Dividend yield
0 / 6Total Cash
269 / 358Performance 3 years
244 / 368Performance 5 years
245 / 368Performance 10 years
218 / 368Linearity 3 years
244 / 368Linearity 5 years
263 / 368Linearity 10 years
220 / 368Total Rank
40 / 368Dividend Rank
184 / 368Valuation Rank
81 / 368Piotroski Rank
32 / 368Muliplier Rank
111 / 368Muliplier Rank - LABP ranking 111 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.